ALK rearranged non–small cell lung carcinoma with EML4-NTRK3 fusion as a possible mechanism of resistance to third-generation ALK inhibitors

  1. Corral de la Fuente, E.
  2. Benito Berlinches, A.
  3. Gomez Rueda, A.
  4. Olmedo García, M.E.
  5. Lage Alfranca, Y.
  6. Lario, M.
  7. Santón Roldán, A.
  8. Garrido, P.
Zeitschrift:
Current Problems in Cancer: Case Reports

ISSN: 2666-6219

Datum der Publikation: 2021

Ausgabe: 4

Art: Artikel

DOI: 10.1016/J.CPCCR.2021.100124 GOOGLE SCHOLAR lock_openOpen Access editor